BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22543453)

  • 1. Smooth muscle actin expression in primary bone tumours.
    Hemingway F; Kashima TG; Mahendra G; Dhongre A; Hogendoorn PC; Mertens F; Athanasou NA
    Virchows Arch; 2012 May; 460(5):525-34. PubMed ID: 22543453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemical differentiation of leiomyocellular tumors and tumors with myogenic differentiation].
    Povýsil C; Ciprová V; Dundr P; Horáková M
    Cesk Patol; 2003 Apr; 39(2):64-8. PubMed ID: 12874903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A diagnosis of giant cell-rich tumour of bone is supported by p63 immunohistochemistry, when more than 50 % of cells is stained.
    Maues De Paula A; Vasiljevic A; Giorgi R; Gomez-Brouchet A; Aubert S; Leroy X; Duval H; de Pinieux G; Bouvier C
    Virchows Arch; 2014 Oct; 465(4):487-94. PubMed ID: 25100342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dentine matrix protein 1 (DMP-1) is a marker of bone-forming tumours.
    Kashima TG; Dongre A; Oppermann U; Athanasou NA
    Virchows Arch; 2013 May; 462(5):583-91. PubMed ID: 23559304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone.
    Ueda T; Araki N; Mano M; Myoui A; Joyama S; Ishiguro S; Yamamura H; Takahashi K; Kudawara I; Yoshikawa H
    J Clin Pathol; 2002 Nov; 55(11):853-8. PubMed ID: 12401825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging of primary bone tumors and tumor-like conditions in children.
    Wootton-Gorges SL
    Magn Reson Imaging Clin N Am; 2009 Aug; 17(3):469-87, vi. PubMed ID: 19524197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma.
    Akpalo H; Lange C; Zustin J
    Histopathology; 2012 Jun; 60(7):1099-106. PubMed ID: 22335248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumors affecting the temporomandibular joint - a literature review].
    Schlund M; Roland-Billecart T; Aubert S; Nicot R
    Bull Cancer; 2020 Nov; 107(11):1186-1198. PubMed ID: 33059872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases.
    Leinauer B; Wolf E; Werner M; Baumhoer D; Breining T; Luebke AM; Maas R; Schultheiß M; von Baer A; Sufi-Siavach A; Moritz C; Geißler S; Mellert K; Möller P; Barth TFE; Jundt G
    Histopathology; 2021 Nov; 79(5):720-730. PubMed ID: 33991114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
    Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
    Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology of bone tumours: diagnostic implications.
    Puls F; Niblett AJ; Mangham DC
    Histopathology; 2014 Mar; 64(4):461-76. PubMed ID: 24428620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone.
    Balla P; Maros ME; Barna G; Antal I; Papp G; Sapi Z; Athanasou NA; Benassi MS; Picci P; Krenacs T
    PLoS One; 2015; 10(5):e0125316. PubMed ID: 25933380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerostin expression in bone tumours and tumour-like lesions.
    Inagaki Y; Hookway ES; Kashima TG; Munemoto M; Tanaka Y; Hassan AB; Oppermann U; Athanasou NA
    Histopathology; 2016 Sep; 69(3):470-8. PubMed ID: 26896083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary bone tumours of the hand. Report of 21 cases.
    Kozlowski K; Azouz EM; Campbell J; Marton D; Morris L; Padovani J; Sprague P; Beluffi G; Berzero GF; Cherubino P
    Pediatr Radiol; 1988; 18(2):140-8. PubMed ID: 3353148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. h-Caldesmon as a specific marker for smooth muscle tumors. Comparison with other smooth muscle markers in bone tumors.
    Watanabe K; Tajino T; Sekiguchi M; Suzuki T
    Am J Clin Pathol; 2000 May; 113(5):663-8. PubMed ID: 10800398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of pedal osseous neoplasms.
    Wu KK
    Clin Podiatr Med Surg; 1993 Oct; 10(4):683-715. PubMed ID: 8221546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics.
    Guimarães LM; Baumhoer D; Andrei V; Friedel D; Koelsche C; Gomez RS; von Deimling A; Gomes CC
    J Pathol Clin Res; 2023 Nov; 9(6):464-474. PubMed ID: 37555357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aneurysmal bone cyst. A review of 123 cases including primary lesions and those secondary to other bone pathology.
    Martinez V; Sissons HA
    Cancer; 1988 Jun; 61(11):2291-304. PubMed ID: 2835141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumors.
    Serra M; Morini MC; Scotlandi K; Fisher LW; Zini N; Colombo MP; Campanacci M; Maraldi NM; Olivari S; Baldini N
    Hum Pathol; 1992 Dec; 23(12):1326-31. PubMed ID: 1468768
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.